SCHEMBL3795344

SCHEMBL3795344

OCc1nc2ccc(-c3ccc4c(c3)CNCCO4)cc2[nH]1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.44
NPSR1 Q6W5P4 1/20 0.41
HDAC6 Q9UBN7 2/20 0.40
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
S1PR1 P21453 2/20 0.39
S1PR3 Q99500 2/20 0.39
PIK3CA P42336 1/20 0.38
AAK1 Q2M2I8 2/20 0.37
CHEK2 O96017 2/20 0.35
DYRK1A Q13627 1/20 0.34
ROCK2 O75116 2/20 0.34
SSTR4 P31391 2/20 0.34
EGFR P00533 1/20 0.33
ERBB2 P04626 1/20 0.33
CD274 Q9NZQ7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3797512 0.82 S1PR1 (0.45) NPSR1HDAC6HDAC3HDAC1HDAC2
SCHEMBL856488 0.82 PIK3CA (0.50) TDP1HDAC6HDAC3HDAC1HDAC2
Hydrochloric Acid SCHEMBL856398 0.81 PIK3CA (0.49) TDP1HDAC6HDAC3HDAC1HDAC2
Bromide SCHEMBL2727893 0.81 PIK3CA (0.49) TDP1HDAC6HDAC3HDAC1HDAC2
Hydrochloric Acid SCHEMBL2726709 0.78 HDAC6 (0.43) HDAC6HDAC3HDAC1HDAC2HDAC8
SCHEMBL3791990 0.77 PIK3CA (0.46) TDP1NPSR1HDAC6HDAC3HDAC1
Trifluoroacetic Acid SCHEMBL2727792 0.74 PIK3CA (0.46) HDAC6HDAC3HDAC1HDAC2HDAC8
Trifluoroacetic Acid SCHEMBL6126953 0.72 PIK3CA (0.44) HDAC6HDAC3HDAC1HDAC2HDAC8
Hydrochloric Acid SCHEMBL15515111 0.72 S1PR1 (0.42) HDAC6HDAC3HDAC1HDAC2HDAC8
SCHEMBL22993338 0.70 ACHE (0.42) S1PR1S1PR3PIK3CACD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010118208-A1 BENZOXAZEPIN-4- (5H) -YL DERIVATIVES AND THEIR USE TO TREAT CANCER EXELIXIS, INC. (US) 2010-10-14 WO disclosed